Microbial Thiamine Factories Using ThiO and ThiI Pathway Engineering

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for thiamine production rely on chemical synthesis using non-renewable fossil fuels, and there is a need for sustainable, bio-based production processes from renewable sources like sugar, with E. coli being a potential microbial cell factory but facing challenges in efficiently producing large amounts of thiamine due to limitations in enzymes like ThiH and ThiI.

Innovation Solution

Replace the E. coli ThiH enzyme with ThiO enzymes from B. subtilis or P. putida and co-express ThiI at optimal levels to enhance the production of dehydroglycine and sulfur transfer, improving the thiamine biosynthesis pathway by incorporating heterologous ThiO and ThiI enzymes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If chemical synthesis process is used for thiamine production, then production efficiency is high, but sustainability is poor due to reliance on non-renewable fossil fuels

Engineering Contradiction:
Improvethiamine production efficiencyVSAvoidenvironmental sustainability
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces the chemical synthesis process (mechanical/chemical system) with a biological system using genetically modified E. coli cells that produce thiamine through metabolic engineering. This substitution enables sustainable production using renewable resources while maintaining high productivity through optimized microbial cell factories

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Adaptability or versatility

If E. coli is engineered to produce thiamine using native ThiH enzyme, then bio-based production is achieved, but production amount is limited due to low enzyme turnover

Engineering Contradiction:
Improvebio-based production capabilityVSAvoidthiamine production amount
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The patent changes the enzyme parameter by replacing the native ThiH enzyme with heterologous ThiO enzymes from B. subtilis or P. putida that have significantly higher turnover numbers. This parameter change increases the catalytic efficiency and enables large-scale thiamine production while maintaining the bio-based production pathway

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite enzymatic system by combining heterologous ThiO enzymes with optimized ThiI enzyme expression. This composite approach integrates multiple enzymatic functions to overcome the limitations of individual enzymes and achieve high-level thiamine production

Inventive Principle:
Principle #40Composite materials

3Reliability

If ThiH enzyme is used for dehydroglycine production, then thiamine pathway is complete, but turnover value is very low limiting production

Engineering Contradiction:
Improvethiamine pathway completenessVSAvoiddehydroglycine production rate
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent changes the kinetic parameter of the dehydroglycine production step by replacing ThiH with ThiO enzymes that have turnover values orders of magnitude higher. This maintains the completeness of the thiamine biosynthesis pathway while dramatically increasing the production rate of dehydroglycine and subsequently thiamine

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Significantly increases thiamine production by up to 300% through optimized expression of ThiO and ThiI enzymes, enhancing the thiamine biosynthesis pathway in genetically modified E. coli cells.

Implementation Method 1

ThiO enzymes from B. subtilis or P. putida...converting glycine into dehydroglycine (DHG)

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 2

ThiI enzymes catalyzing the transfer of sulfur from IscS to the sulfur carrier protein ThiS

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentUS20260022411A1Microbial cell factories producing thiamine
Publication Date: 2026.01.22 BIOSYNTIA APS
  • US20260022411A1 patent drawing
  • US20260022411A1 patent drawing
  • US20260022411A1 patent drawing

AI summary

The present disclosure relates to a genetically modified host cell having improved production of thiamine, wherein the host cell expresses one or more heterologous ThiO enzymes converting glycine into dehydroglycine (DHG) in the host cell and/or one or more heterologous ThiI enzymes catalyzing the transfer of sulfur from IscS to the sulfur carrier protein ThiS in the host cell, whereby the production of the thiamine in the genetically modified host cell is improved compared to an unmodified parent host cell.